STOCK OPTIONS AND WARRANTS (Details 4) - $ / shares |
1 Months Ended | 3 Months Ended |
|---|---|---|
Mar. 29, 2023 |
Mar. 31, 2023 |
|
| Exercisable, Number of Options | 876,488 | |
| Exercise price | $ 4.00 | |
| Warrants Exercisable [Member] | ||
| Weighted average remaining life in years | 2 years 7 months 6 days | |
| Exercisable, Number of Options | 676,447 | |
| Exercise price | $ 4.53 | |
| Warrants Exercisable [Member] | 4.53 [Member] | ||
| Weighted average remaining life in years | 2 years 7 months 6 days | |
| Exercisable, Number of Options | 676,447 | |
| Warrants Outstanding [Member] | ||
| Weighted average remaining life in years | 2 years 7 months 6 days | |
| Exercise price | $ 4.53 | |
| Number of outstanding | 676,447 | |
| Warrants Outstanding [Member] | 4.53 [Member] | ||
| Weighted average remaining life in years | 2 years 7 months 6 days | |
| Number of outstanding | 676,447 |
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|